project id: TCGA-STAD; case submitter id: TCGA-SW-A7EB; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.94; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.62; rna integrity number: 7.7; age at index: 45; days to birth: -16475; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1968; age at diagnosis: 16475; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 176.0; icd 10 code: C16.3; last known disease status: not reported; morphology: 8480/3; primary diagnosis: Mucinous adenocarcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Gastric antrum; synchronous malignancy: No; tissue or organ of origin: Gastric antrum; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 77; days to sample procurement: 0; initial weight: 720.0; portion submitter id: TCGA-SW-A7EB-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;